| Trial ID: | L0666 |
| Source ID: | NCT01703234
|
| Associated Drug: |
Ramipril
|
| Title: |
FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Proteinuria|Diabetic Nephropathy|Chronic Kidney Disease
|
| Interventions: |
DRUG: Ramipril
|
| Outcome Measures: |
Primary: Flow Mediated Dilatation | Secondary: FGF-23
|
| Sponsor/Collaborators: |
Sponsor: Gulhane School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
78
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-01
|
| Completion Date: |
2009-04
|
| Results First Posted: |
|
| Last Update Posted: |
2012-10-10
|
| Locations: |
Gulhane School of Medicine, Ankara, Turkey
|
| URL: |
https://clinicaltrials.gov/show/NCT01703234
|
